Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience.
This study was designed to evaluate the safety and performance of Metafor™ SES in real-world patients with coronary artery disease. This was retrospective, single-centre, post-marketing, observational study. The primary endpoint was the occurrence of major adverse cardiac event (MACE). A total of 14...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-01-01
|
| Series: | Indian Heart Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483220304594 |
| _version_ | 1830191612524756992 |
|---|---|
| author | Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC, FSCAI, Fellowship in Interventional Cardiology (ICPS, Paris, France) Rohithreddy Poondru, MD, DM Guru Prakash Avvuri, MD, DM Narasa Raju Kavalipati, MD, DM Pramod Kumar Kuchulakanti, MD, DM |
| author_facet | Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC, FSCAI, Fellowship in Interventional Cardiology (ICPS, Paris, France) Rohithreddy Poondru, MD, DM Guru Prakash Avvuri, MD, DM Narasa Raju Kavalipati, MD, DM Pramod Kumar Kuchulakanti, MD, DM |
| author_sort | Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC, FSCAI, Fellowship in Interventional Cardiology (ICPS, Paris, France) |
| collection | DOAJ |
| description | This study was designed to evaluate the safety and performance of Metafor™ SES in real-world patients with coronary artery disease. This was retrospective, single-centre, post-marketing, observational study. The primary endpoint was the occurrence of major adverse cardiac event (MACE). A total of 141 patients (187 lesions) were treated with the study device. The average stent length and diameter was 24.75 ± 9.50 mm and 2.93 ± 0.38 mm, respectively. The cumulative incidence of MACE was 1.42%. No incidence of stent thrombosis was observed at 12-months follow-up. This retrospective study demonstrated favourable safety and performance of Metafor™ SES. |
| first_indexed | 2024-12-17T23:41:58Z |
| format | Article |
| id | doaj.art-ccfa92e90af64f98a5ae420393b28c89 |
| institution | Directory Open Access Journal |
| issn | 0019-4832 |
| language | English |
| last_indexed | 2024-12-17T23:41:58Z |
| publishDate | 2021-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Indian Heart Journal |
| spelling | doaj.art-ccfa92e90af64f98a5ae420393b28c892022-12-21T21:28:25ZengElsevierIndian Heart Journal0019-48322021-01-01731114116Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience.Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC, FSCAI, Fellowship in Interventional Cardiology (ICPS, Paris, France)0Rohithreddy Poondru, MD, DM1Guru Prakash Avvuri, MD, DM2Narasa Raju Kavalipati, MD, DM3Pramod Kumar Kuchulakanti, MD, DM4Corresponding author.; Department of Cardiology, Yashoda Hospitals, Somajiguda, Hyderabad, Telangana, 500063, IndiaDepartment of Cardiology, Yashoda Hospitals, Somajiguda, Hyderabad, Telangana, 500063, IndiaDepartment of Cardiology, Yashoda Hospitals, Somajiguda, Hyderabad, Telangana, 500063, IndiaDepartment of Cardiology, Yashoda Hospitals, Somajiguda, Hyderabad, Telangana, 500063, IndiaDepartment of Cardiology, Yashoda Hospitals, Somajiguda, Hyderabad, Telangana, 500063, IndiaThis study was designed to evaluate the safety and performance of Metafor™ SES in real-world patients with coronary artery disease. This was retrospective, single-centre, post-marketing, observational study. The primary endpoint was the occurrence of major adverse cardiac event (MACE). A total of 141 patients (187 lesions) were treated with the study device. The average stent length and diameter was 24.75 ± 9.50 mm and 2.93 ± 0.38 mm, respectively. The cumulative incidence of MACE was 1.42%. No incidence of stent thrombosis was observed at 12-months follow-up. This retrospective study demonstrated favourable safety and performance of Metafor™ SES.http://www.sciencedirect.com/science/article/pii/S0019483220304594Biodegradable polymerDrug-eluting stentPercutaneous coronary intervention |
| spellingShingle | Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC, FSCAI, Fellowship in Interventional Cardiology (ICPS, Paris, France) Rohithreddy Poondru, MD, DM Guru Prakash Avvuri, MD, DM Narasa Raju Kavalipati, MD, DM Pramod Kumar Kuchulakanti, MD, DM Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience. Indian Heart Journal Biodegradable polymer Drug-eluting stent Percutaneous coronary intervention |
| title | Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience. |
| title_full | Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience. |
| title_fullStr | Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience. |
| title_full_unstemmed | Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience. |
| title_short | Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience. |
| title_sort | twelve months clinical outcomes of biodegradable polymer coated sirolimus eluting coronary stent in real world patients a single center experience |
| topic | Biodegradable polymer Drug-eluting stent Percutaneous coronary intervention |
| url | http://www.sciencedirect.com/science/article/pii/S0019483220304594 |
| work_keys_str_mv | AT pankajjariwalamddnbdnbmnamsficpsfaccfscaifellowshipininterventionalcardiologyicpsparisfrance twelvemonthsclinicaloutcomesofbiodegradablepolymercoatedsirolimuselutingcoronarystentinrealworldpatientsasinglecenterexperience AT rohithreddypoondrumddm twelvemonthsclinicaloutcomesofbiodegradablepolymercoatedsirolimuselutingcoronarystentinrealworldpatientsasinglecenterexperience AT guruprakashavvurimddm twelvemonthsclinicaloutcomesofbiodegradablepolymercoatedsirolimuselutingcoronarystentinrealworldpatientsasinglecenterexperience AT narasarajukavalipatimddm twelvemonthsclinicaloutcomesofbiodegradablepolymercoatedsirolimuselutingcoronarystentinrealworldpatientsasinglecenterexperience AT pramodkumarkuchulakantimddm twelvemonthsclinicaloutcomesofbiodegradablepolymercoatedsirolimuselutingcoronarystentinrealworldpatientsasinglecenterexperience |